Description
Clinical Use
To identify patients at greater risk for developing Alzheimer’s disease or other neurological disorder.
To identify reactivity to triggers of Alzheimer’s disease or other neurological disorder.
To identify the early stage of neurodegenerative processes.
To monitor the effectiveness of lifestyle modifications for Alzheimer’s disease.
Recommended for patients who:
- Are interested in preventing the development of Alzheimer’s disease or other neurological disorder.
- Are exhibiting early signs of Alzheimer’s disease or other neurological disorder.
- Have been diagnosed with Alzheimer’s disease.
- Have a history of gastrointestinal disorders and/or diabetes.
- Played high-impact sports.
- Are immunoreactive against specific pathogens, chemicals and foods.
Antigens Tested
Brain Proteins
Tau Protein IgG
Amyloid-Beta Peptide IgG
Rabaptin-5 + Presenilin IgG
Alpha-Synuclein IgG
Growth Factors
Beta Nerve Growth Factor IgG
Brain Derived Neurotrophic Factor IgG
Neurotrophins IgG
Somatotropin IgG
Enteric Nerve, Enzymes and Neurological Peptides
Enteric Nerve + Vasoactive Intestinal Peptide IgG
Transglutaminases IgG
Pathogens
Oral Pathogens IgG
Enterococcus faecalis IgG
Escherichia coli CDT + Salmonella CDT IgG
Campylobacter jejuni CDT IgG
Herpes Type-1 IgG
Chemicals
Aluminums IgG
Dinitrophenyl IgG
Ethyl + Methyl Mercury IgG
Phthalates IgG
Foods Cross-Reactive to Amyloid-Beta
Egg Yolk, raw + cooked IgG
Lentil Lectin + Pea Lectin IgG
Tuna, canned IgG
Hazelnut Vicilin + Cashew Vicilin IgG
Scallops + Squid IgG
Caseins IgG
Alpha-Gliadin + Gliadin Toxic Peptide IgG
Non-Gluten Wheat Proteins IgG
Blood-Brain Barrier and Neurofilaments
Blood-Brain Barrier Protein + Claudin-5 IgG
Aquaporins IgG
Neurofilaments Proteins IgG
Alzheimer’s LINXTM — Alzheimer’s-Associated Immune Reactivity